Accordingly, inactivating mutations of p300 and CBP have been reported in follicular lymphoma, diffuse large B-cell lymphoma, small cell lung cancer and endometrial cancer [9], [10], [11]. The gene discussed is EP300; the disease is small cell lung carcinoma.